Outcomes Following Delta Xtend Reverse Shoulder System
1 other identifier
observational
N/A
1 country
1
Brief Summary
To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2013
CompletedFirst Posted
Study publicly available on registry
December 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedDecember 18, 2013
December 1, 2013
December 12, 2013
December 17, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Implant Survivorship
10 years post-operative
Study Arms (1)
DePuy Delta Xtend RTSA
Interventions
Eligibility Criteria
patients who were implanted with the DePuy Delta Xtend Reverse Total Shoulder Arthoplasty between 2008-2012
You may qualify if:
- Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothman Institute
Philadelphia, Pennsylvania, 19107, United States
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2013
First Posted
December 18, 2013
Primary Completion
March 1, 2020
Last Updated
December 18, 2013
Record last verified: 2013-12